The combination of canagliflozin and omega-3 fatty acid ameliorates insulin resistance and cardiac biomarkers <i>via</i> modulation of inflammatory cytokines in type 2 diabetic rats.

Safhi, Mohammed Mohsen; Anwer, Tarique; Khan, Gyas; Siddiqui, Rahimullah; Moni Sivakumar, Sivagurunathan; Alam, Mohammad Firoz

The combination of canagliflozin and omega-3 fatty acid ameliorates insulin resistance and cardiac biomarkers via modulation of inflammatory cytokines in type 2 diabetic rats.

Safhi, Mohammed Mohsen; Anwer, Tarique; Khan, Gyas; Siddiqui, Rahimullah; Moni Sivakumar, Sivagurunathan; Alam, Mohammad Firoz.

Afiliação

Safhi MM; Department of Pharmacology, College of Pharmacy, Jazan University, Gizan 45142, Saudi Arabia.
Anwer T; Department of Pharmacology, College of Pharmacy, Jazan University, Gizan 45142, Saudi Arabia.
Khan G; Department of Pharmacology, College of Pharmacy, Jazan University, Gizan 45142, Saudi Arabia.
Siddiqui R; Department of Pharmacology, College of Pharmacy, Jazan University, Gizan 45142, Saudi Arabia.
Moni Sivakumar S; Department of Pharmaceutics, College of Pharmacy, Jazan University, Gizan 45142, Saudi Arabia.
Alam MF; Department of Pharmacology, College of Pharmacy, Jazan University, Gizan 45142, Saudi Arabia.

Korean J Physiol Pharmacol ; 22(5): 493-501, 2018 Sep.

Article em En | MEDLINE | ID: mdl-30181696